Cargando…
An engineered monomer binding-protein for α-synuclein efficiently inhibits the proliferation of amyloid fibrils
Removing or preventing the formation of [Formula: see text]-synuclein aggregates is a plausible strategy against Parkinson’s disease. To this end, we have engineered the [Formula: see text]-wrapin AS69 to bind monomeric [Formula: see text]-synuclein with high affinity. In cultured cells, AS69 reduce...
Autores principales: | Agerschou, Emil Dandanell, Flagmeier, Patrick, Saridaki, Theodora, Galvagnion, Céline, Komnig, Daniel, Heid, Laetitia, Prasad, Vibha, Shaykhalishahi, Hamed, Willbold, Dieter, Dobson, Christopher M, Voigt, Aaron, Falkenburger, Bjoern, Hoyer, Wolfgang, Buell, Alexander K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721797/ https://www.ncbi.nlm.nih.gov/pubmed/31389332 http://dx.doi.org/10.7554/eLife.46112 |
Ejemplares similares
-
A β-Wrapin Targeting the N-Terminus of α-Synuclein Monomers Reduces Fibril-Induced Aggregation in Neurons
por: Szegő, Éva M., et al.
Publicado: (2021) -
Inhibitor and substrate cooperate to inhibit amyloid fibril elongation of α-synuclein
por: Agerschou, Emil Dandanell, et al.
Publicado: (2020) -
Opposed Effects of Dityrosine Formation in Soluble and Aggregated α-Synuclein on Fibril Growth
por: Wördehoff, Michael M., et al.
Publicado: (2017) -
Structural insights from lipid-bilayer nanodiscs link α-Synuclein membrane-binding modes to amyloid fibril formation
por: Viennet, Thibault, et al.
Publicado: (2018) -
Alpha-Synuclein-Specific Naturally Occurring Antibodies Inhibit Aggregation In Vitro and In Vivo
por: Braczynski, Anne K., et al.
Publicado: (2022)